Active Pharmaceutical Ingredients - Global Market Outlook (2017-2026)

Active Pharmaceutical Ingredients - Global Market Outlook (2017-2026)

  • Published: September 2018
  • ID: SMRC17603

According to Stratistics MRC, the Global Active Pharmaceutical Ingredients Market is accounted for $151.89 billion in 2017 and is expected to reach $308.48 billion by 2026 growing at a CAGR of 8.2% from 2017 to 2026. Increase in incidence of chronic diseases, rising prevalence of cancer, technological advancements in API manufacturing, growing importance of generics, rapidly increasing geriatric population, increase in abbreviated new drug applications (ANDA) and increasing uptake of biopharmaceuticals are some factors fueling the market growth. However, factors such as stringent regulatory requirements and unfavorable drug price control policies across various countries are restricting the market growth.                         
               
Active pharmaceutical ingredients are any substance or combination of substances used in a finished pharmaceutical product with pharmacological activity. Active Pharmaceutical Ingredients are chemically and biologically active components of drugs with direct effect in cure, mitigation, treatment and prevention of diseases. An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine, and the term active substance may be used for natural products. Some medication products may contain more than one active ingredient. The traditional word for the API is pharmacon or pharmakon which originally denoted a magical substance or drug.   
        
Amongst API Formulation, Generic segment accounted for significant market share during the forecast period. Generic drugs benefit from the patent expiration of innovative drug as it makes them readily available in the market. The demand to produce quality medicines at lower and affordable costs creates a scenario, where the needs for generic drugs increase. By geography, Asia Pacific dominated the market due to the rising healthcare spending which has led to quality healthcare becoming accessible along with a higher demand for pharmaceutical products across APAC. The pharmaceuticals consumed here are mostly produced in onshore manufacturing units. Furthermore, contract manufacturing organizations are key outsourcing allies for pharmaceutical companies that supply their wares across the region.

Some of the key players in Active Pharmaceutical Ingredients market include Teva Active Pharmaceutical Industries Limited, Ranbaxy Laboratories, Pfizer, Inc, Novartis, Mylan N.V, Lupin, Dr. Reddy's Lab, Boehringer Ingelheim GmbH, Aurobindo pharma, Albemarle Corporation, Ceva Animal Health, Inc., Virbac, Sun Pharmaceutical Industries Ltd., Merck Animal Health (U.S.), Elanco Animal Health (U.S.), Zoetis (U.S.), Merial Inc. (Sanofi) (France), Bioniche Animal Health (Canada), Bayer Healthcare (Germany), ELI Lilly and Company, Glaxosmithkline PLC, Abbvie Inc., Sanofi and Bristol-Myers Squibb.

Drug Types Covered:
• Generic Prescription
• Innovative Drugs
• Over-the-counter (OTC) Drugs
• Prescription Drugs
• Potency

API Formulations Covered:
• Innovative API
• Generic API

Type of Manufacturers Covered:
• Contract Manufacturers
• Captive Manufacturers
• Merchant API Manufacturers

Type of Synthesises Covered:
• Biotech Active Pharmaceutical Ingredients
• Synthetic Active Pharmaceutical Ingredients

API Types Covered:
• Biological API
• Chemical API

Molecules Covered:
• Large Molecule
• Small Molecule

Applications Covered:
• Anti-diabetic Drugs
• Cardiovascular Disease
• Central Nervous System and Neurological Disorders
• Diabetes
• Endocrinology
• Gastrointestinal Disorders
• Musculoskeletal drugs
• Non-steroidal Anti-inflammatory Drugs
• Oncology
• Orthopedic Disorders
• Respiratory
• Urology
• Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan       
    • China       
    • India       
    • Australia 
    • New Zealand     
    • South Korea      
    • Rest of Asia Pacific   
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

1 Executive Summary   
     
2 Preface    
 2.1 Abstract   
 2.2 Stake Holders  
 2.3 Research Scope  
 2.4 Research Methodology 
  2.4.1 Data Mining 
  2.4.2 Data Analysis 
  2.4.3 Data Validation 
  2.4.4 Research Approach 
 2.5 Research Sources  
  2.5.1 Primary Research Sources
  2.5.2 Secondary Research Sources
  2.5.3 Assumptions 
     
3 Market Trend Analysis  
 3.1 Introduction  
 3.2 Drivers   
 3.3 Restraints  
 3.4 Opportunities  
 3.5 Threats   
 3.6 Application Analysis 
 3.7 Emerging Markets  
 3.8 Futuristic Market Scenario 
     
4 Porters Five Force Analysis  
 4.1 Bargaining power of suppliers 
 4.2 Bargaining power of buyers 
 4.3 Threat of substitutes 
 4.4 Threat of new entrants 
 4.5 Competitive rivalry  
     
5 Global Active Pharmaceutical Ingredients Market, By Drug Type
 5.1 Introduction  
 5.2 Generic Prescription 
 5.3 Innovative Drugs  
 5.4 Over-the-counter (OTC) Drugs 
 5.5 Prescription Drugs  
 5.6 Potency    
  5.6.1 Low to Moderate Potency
  5.6.2 Potent to Highly Potent
     
6 Global Active Pharmaceutical Ingredients Market, By API Formulation

 6.1 Introduction  
 6.2 Innovative API  
 6.3 Generic API  
     
7 Global Active Pharmaceutical Ingredients Market, By Type of Manufacturer
 7.1 Introduction  
 7.2 Contract Manufacturers 
 7.3 Captive Manufacturers 
 7.4 Merchant API Manufacturers 
  7.4.1 Generic Merchant API Manufacturers
  7.4.2 Innovative Merchant API Manufacturers
     
8 Global Active Pharmaceutical Ingredients Market, By Type of Synthesis
 8.1 Introduction  
 8.2 Biotech Active Pharmaceutical Ingredients
  8.2.1 Type  
   8.2.1.1 Biosimilars
   8.2.1.2 Innovative Biotech APIs
  8.2.2 Expression System 
   8.2.2.1 Insect Expression Systems
   8.2.2.2 Mammalian Expression Systems
   8.2.2.3 Microbial Expression Systems
   8.2.2.4 Plant Expression Systems
   8.2.2.5 Yeast Expression Systems
  8.2.3 Product  
   8.2.3.1 Blood Factors
   8.2.3.2 Cytokines
   8.2.3.3 Fusion Proteins
   8.2.3.4 Hormones and Growth Factors
   8.2.3.5 Monoclonal Antibodies
   8.2.3.6 Therapeutic Enzymes
   8.2.3.7 Vaccines 
 8.3 Synthetic Active Pharmaceutical Ingredients
  8.3.1 Generic Synthetic APIs
  8.3.2 Innovative Synthetic APIs
     
9 Global Active Pharmaceutical Ingredients Market, By API Type
 9.1 Introduction  
 9.2 Biological API  
 9.3 Chemical API  
     
10 Global Active Pharmaceutical Ingredients Market, By Molecule
 10.1 Introduction   
 10.2 Large Molecule  
 10.3 Small Molecule  
     
11 Global Active Pharmaceutical Ingredients Market, By Application
 11.1 Introduction  
 11.2 Anti-diabetic Drugs  
 11.3 Cardiovascular Disease  
 11.4 Central Nervous System and Neurological Disorders
 11.5 Diabetes    
 11.6 Endocrinology   
 11.7 Gastrointestinal Disorders 
 11.8 Musculoskeletal drugs 
 11.9 Non-steroidal Anti-inflammatory Drugs
 11.10 Oncology   
 11.11 Orthopedic Disorders 
 11.12 Respiratory  
 11.13 Urology   
 11.14 Other Applications  
     
12 Global Active Pharmaceutical Ingredients Market, By Geography
 12.1 Introduction  
 12.2 North America  
  12.2.1 US  
  12.2.2 Canada  
  12.2.3 Mexico  
 12.3 Europe   
  12.3.1 Germany  
  12.3.2 UK  
  12.3.3 Italy  
  12.3.4 France  
  12.3.5 Spain  
  12.3.6 Rest of Europe 
 12.4 Asia Pacific  
  12.4.1 Japan  
  12.4.2 China  
  12.4.3 India  
  12.4.4 Australia  
  12.4.5 New Zealand 
  12.4.6 South Korea 
  12.4.7 Rest of Asia Pacific 
 12.5 South America  
  12.5.1 Argentina 
  12.5.2 Brazil  
  12.5.3 Chile  
  12.5.4 Rest of South America
 12.6 Middle East & Africa 
  12.6.1 Saudi Arabia 
  12.6.2 UAE  
  12.6.3 Qatar  
  12.6.4 South Africa 
  12.6.5 Rest of Middle East & Africa
     
13 Key Developments   
 13.1 Agreements, Partnerships, Collaborations and Joint Ventures
 13.2 Acquisitions & Mergers 
 13.3 New Product Launch 
 13.4 Expansions  
 13.5 Other Key Strategies 
     
14 Company Profiling   
 14.1 Teva Active Pharmaceutical Industries Limited
 14.2 Ranbaxy Laboratories 
 14.3 Pfizer, Inc  
 14.4 Novartis   
 14.5 Mylan N.V  
 14.6 Lupin   
 14.7 Dr. Reddy's Lab  
 14.8 Boehringer Ingelheim GmbH 
 14.9 Aurobindo pharma  
 14.10 Albemarle Corporation 
 14.11 Ceva Animal Health, Inc. 
 14.12 Virbac   
 14.13 Sun Pharmaceutical Industries Ltd.
 14.14 Merck Animal Health (U.S.) 
 14.15 Elanco Animal Health (U.S.) 
 14.16 Zoetis (U.S.)           
 14.17 Merial Inc. (Sanofi) (France)      
 14.18 Bioniche Animal Health (Canada)      
 14.19 Bayer Healthcare (Germany)      
 14.20 ELI Lilly and Company  
 14.21 Glaxosmithkline PLC  
 14.22 Abbvie Inc.  
 14.23 Sanofi    
 14.24 Bristol-Myers Squibb  


List of Tables    
1 Global Active Pharmaceutical Ingredients Market Outlook, By Region (2016-2026) (US $MN)
2 Global Active Pharmaceutical Ingredients Market Outlook, By Drug Type (2016-2026) (US $MN)
3 Global Active Pharmaceutical Ingredients Market Outlook, By Generic Prescription (2016-2026) (US $MN)
4 Global Active Pharmaceutical Ingredients Market Outlook, By Innovative Drugs (2016-2026) (US $MN)
5 Global Active Pharmaceutical Ingredients Market Outlook, By Over-the-counter (OTC) Drugs (2016-2026) (US $MN)
6 Global Active Pharmaceutical Ingredients Market Outlook, By Prescription Drugs (2016-2026) (US $MN)
7 Global Active Pharmaceutical Ingredients Market Outlook, By Potency (2016-2026) (US $MN)
8 Global Active Pharmaceutical Ingredients Market Outlook, By Low to Moderate Potency (2016-2026) (US $MN)
9 Global Active Pharmaceutical Ingredients Market Outlook, By Potent to Highly Potent (2016-2026) (US $MN)
10 Global Active Pharmaceutical Ingredients Market Outlook, By API Formulation (2016-2026) (US $MN)
11 Global Active Pharmaceutical Ingredients Market Outlook, By Innovative API (2016-2026) (US $MN)
12 Global Active Pharmaceutical Ingredients Market Outlook, By Generic API (2016-2026) (US $MN)
13 Global Active Pharmaceutical Ingredients Market Outlook, By Type of Manufacturer (2016-2026) (US $MN)
14 Global Active Pharmaceutical Ingredients Market Outlook, By Contract Manufacturers (2016-2026) (US $MN)
15 Global Active Pharmaceutical Ingredients Market Outlook, By Captive Manufacturers (2016-2026) (US $MN)
16 Global Active Pharmaceutical Ingredients Market Outlook, By Merchant API Manufacturers (2016-2026) (US $MN)
17 Global Active Pharmaceutical Ingredients Market Outlook, By Generic Merchant API Manufacturers (2016-2026) (US $MN)
18 Global Active Pharmaceutical Ingredients Market Outlook, By Innovative Merchant API Manufacturers (2016-2026) (US $MN)
19 Global Active Pharmaceutical Ingredients Market Outlook, By Type of Synthesis (2016-2026) (US $MN)
20 Global Active Pharmaceutical Ingredients Market Outlook, By Biotech Active Pharmaceutical Ingredients (2016-2026) (US $MN)
21 Global Active Pharmaceutical Ingredients Market Outlook, By Type (2016-2026) (US $MN)
22 Global Active Pharmaceutical Ingredients Market Outlook, By Expression System (2016-2026) (US $MN)
23 Global Active Pharmaceutical Ingredients Market Outlook, By Product (2016-2026) (US $MN)
24 Global Active Pharmaceutical Ingredients Market Outlook, By Synthetic Active Pharmaceutical Ingredients (2016-2026) (US $MN)
25 Global Active Pharmaceutical Ingredients Market Outlook, By Generic Synthetic APIs (2016-2026) (US $MN)
26 Global Active Pharmaceutical Ingredients Market Outlook, By Innovative Synthetic APIs (2016-2026) (US $MN)
27 Global Active Pharmaceutical Ingredients Market Outlook, By API Type (2016-2026) (US $MN)
28 Global Active Pharmaceutical Ingredients Market Outlook, By Biological API (2016-2026) (US $MN)
29 Global Active Pharmaceutical Ingredients Market Outlook, By Chemical API (2016-2026) (US $MN)
30 Global Active Pharmaceutical Ingredients Market Outlook, By Molecule (2016-2026) (US $MN)
31 Global Active Pharmaceutical Ingredients Market Outlook, By Large Molecule (2016-2026) (US $MN)
32 Global Active Pharmaceutical Ingredients Market Outlook, By Small Molecule (2016-2026) (US $MN)
33 Global Active Pharmaceutical Ingredients Market Outlook, By Application (2016-2026) (US $MN)
34 Global Active Pharmaceutical Ingredients Market Outlook, By Anti-diabetic Drugs (2016-2026) (US $MN)
35 Global Active Pharmaceutical Ingredients Market Outlook, By Cardiovascular Disease (2016-2026) (US $MN)
36 Global Active Pharmaceutical Ingredients Market Outlook, By Central Nervous System and Neurological Disorders (2016-2026) (US $MN)
37 Global Active Pharmaceutical Ingredients Market Outlook, By Diabetes (2016-2026) (US $MN)
38 Global Active Pharmaceutical Ingredients Market Outlook, By Endocrinology (2016-2026) (US $MN)
39 Global Active Pharmaceutical Ingredients Market Outlook, By Gastrointestinal Disorders (2016-2026) (US $MN)
40 Global Active Pharmaceutical Ingredients Market Outlook, By Musculoskeletal drugs (2016-2026) (US $MN)
41 Global Active Pharmaceutical Ingredients Market Outlook, By Non-steroidal Anti-inflammatory Drugs (2016-2026) (US $MN)
42 Global Active Pharmaceutical Ingredients Market Outlook, By Oncology (2016-2026) (US $MN)
43 Global Active Pharmaceutical Ingredients Market Outlook, By Orthopedic Disorders (2016-2026) (US $MN)
44 Global Active Pharmaceutical Ingredients Market Outlook, By Respiratory (2016-2026) (US $MN)
45 Global Active Pharmaceutical Ingredients Market Outlook, By Urology (2016-2026) (US $MN)
46 Global Active Pharmaceutical Ingredients Market Outlook, By Other Applications (2016-2026) (US $MN)
     
NOTE: Tables for North America, Europe, Asia Pacific, South America and Middle East & Africa are represented in the same manner above.

1. What do I do if I have a query on this report?
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: [email protected] or phone: +1-301-202-5929
2. Is the sample available for this report? Can I request the sample with my specific requirements?
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
3. Format of the report?
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: [email protected] or phone: +1-301-202-5929
4. Services prior to purchase and after purchase?
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at [email protected] or call us on +1-301-202-5929.
5. License Type and Delivery?
We have 3 different licensing options available in electronic format.
  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment
6. Purchase procedure and Invoicing?
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards
7. Post sale support?
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at [email protected] or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Single User License (PDF)

 

2 - 5 User License (PDF)

 

Site License (PDF)

 

Corporate License (PDF)

 

Have a Question?


Know our Methodology

WHY CHOOSE US ?

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Adding more values to your product of interest.

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials